Found: 6
Select item for more details and to access through your institution.
Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors.
- Published in:
- Cell & Bioscience, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13578-024-01271-z
- By:
- Publication type:
- Article
LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 17, p. 1, doi. 10.1002/cam4.70169
- By:
- Publication type:
- Article
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 7, p. 1334, doi. 10.1002/mc.23727
- By:
- Publication type:
- Article
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 1, p. 75, doi. 10.1002/mc.23637
- By:
- Publication type:
- Article
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 5, p. 677, doi. 10.1007/s10120-023-01402-4
- By:
- Publication type:
- Article
Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib.
- Published in:
- Reports of Biochemistry & Molecular Biology, 2023, v. 12, n. 1, p. 74
- By:
- Publication type:
- Article